CCND3-EHMT2 Fusion FISH Probe
The CCND3-EHMT2 Fusion FISH Probe is used to confirm a fusion of the CCND3 and EHMT2 genes. The fusion of the CCND3 and EHMT2 genes has been associated with Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CCND3-EHMT2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CCND3-EHMT2-20-AQAQ | 20 (40 μL) | 200 μL |
|
CCND3 Gene Summary
The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance through the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activtiy is required for cell cycle G1/S transition. This protein has been shown to interact with and be involved in the phosphorylation of tumor suppressor protein Rb. The CDK4 activity associated with this cyclin was reported to be necessary for cell cycle progression through G2 phase into mitosis after UV radiation. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
Gene Name: Cyclin D3
Chromosome: CHR6: 41902670 -42016610
Locus: 6p21.1
EHMT2 Gene Summary
This gene encodes a methyltransferase that methylates lysine residues of histone H3. Methylation of H3 at lysine 9 by this protein results in recruitment of additional epigenetic regulators and repression of transcription. This gene was initially thought to be two different genes, NG36 and G9a, adjacent to each other in the HLA locus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Gene Name: Euchromatic Histone Lysine Methyltransferase 2
Chromosome: CHR6_mcf_hap5: 3227409 -3245344
Locus: 6p21.33
Gene Diseases
The CCND3 EHMT2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|